Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

Similar articles for PubMed (Select 22143423)


Cardiovascular magnetic resonance imaging (CMR) reveals characteristic pattern of myocardial damage in patients with mitochondrial myopathy.

Yilmaz A, Gdynia HJ, Ponfick M, Rösch S, Lindner A, Ludolph AC, Sechtem U.

Clin Res Cardiol. 2012 Apr;101(4):255-61. doi: 10.1007/s00392-011-0387-z. Epub 2011 Dec 6.


CMR gives clue to "ragged red fibers" in the heart in a patient with mitochondrial myopathy.

Jose T, Gdynia HJ, Mahrholdt H, Vöhringer M, Klingel K, Kandolf R, Bornemann A, Yilmaz A.

Int J Cardiol. 2011 May 19;149(1):e24-7. doi: 10.1016/j.ijcard.2009.03.057. Epub 2009 Apr 2.


[Cardiac involvement in mitochondrial disease: a clinical study of 38 patients].

Anan R.

Igaku Kenkyu. 1991 Sep;61(2):49-61. Japanese.


Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease.

Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB.

Circulation. 2006 Jun 13;113(23):2733-43. Epub 2006 Jun 5. Erratum in: Circulation. 2006 Aug 22;114(8):e365.


Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach.

Yilmaz A, Gdynia HJ, Baccouche H, Mahrholdt H, Meinhardt G, Basso C, Thiene G, Sperfeld AD, Ludolph AC, Sechtem U.

J Cardiovasc Magn Reson. 2008 Nov 4;10:50. doi: 10.1186/1532-429X-10-50.


CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Papavassiliu T, Germans T, Flüchter S, Doesch C, Suriyakamar A, Haghi D, Süselbeck T, Wolpert C, Dinter D, Schoenberg SO, van Rossum AC, Borggrefe M.

J Cardiovasc Magn Reson. 2009 Sep 9;11:34. doi: 10.1186/1532-429X-11-34.


Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.

Mark PB, Johnston N, Groenning BA, Foster JE, Blyth KG, Martin TN, Steedman T, Dargie HJ, Jardine AG.

Kidney Int. 2006 May;69(10):1839-45.


Myocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with "pure" apical hypertrophic cardiomyopathy.

Kim KH, Kim HK, Hwang IC, Lee SP, Park EA, Lee W, Kim YJ, Park JH, Sohn DW.

J Cardiovasc Magn Reson. 2012 Jul 28;14:52. doi: 10.1186/1532-429X-14-52.


Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis.

Zagrosek A, Abdel-Aty H, Boyé P, Wassmuth R, Messroghli D, Utz W, Rudolph A, Bohl S, Dietz R, Schulz-Menger J.

JACC Cardiovasc Imaging. 2009 Feb;2(2):131-8. doi: 10.1016/j.jcmg.2008.09.014.


Systematic analysis of functional and structural changes after coronary microembolization: a cardiac magnetic resonance imaging study.

Breuckmann F, Nassenstein K, Bucher C, Konietzka I, Kaiser G, Konorza T, Naber C, Skyschally A, Gres P, Heusch G, Erbel R, Barkhausen J.

JACC Cardiovasc Imaging. 2009 Feb;2(2):121-30. doi: 10.1016/j.jcmg.2008.10.011.


Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.

Ntusi NA, Piechnik SK, Francis JM, Ferreira VM, Rai AB, Matthews PM, Robson MD, Moon J, Wordsworth PB, Neubauer S, Karamitsos TD.

J Cardiovasc Magn Reson. 2014 Mar 4;16:21. doi: 10.1186/1532-429X-16-21.


Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation.

Nagai T, Kohsaka S, Okuda S, Anzai T, Asano K, Fukuda K.

Chest. 2014 Oct;146(4):1064-72. doi: 10.1378/chest.14-0139.


Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.

Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD, Friedrich MG, Neubauer S.

J Cardiovasc Magn Reson. 2014 May 23;16:36. doi: 10.1186/1532-429X-16-36.


[Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].

Dumont CA, Monserrat L, Soler R, Rodríguez E, Fernández X, Peteiro J, Bouzas B, Piñón P, Castro-Beiras A.

Rev Esp Cardiol. 2007 Jan;60(1):15-23. Spanish.


Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.

Green JJ, Berger JS, Kramer CM, Salerno M.

JACC Cardiovasc Imaging. 2012 Apr;5(4):370-7. doi: 10.1016/j.jcmg.2011.11.021. Review.


Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.

Moon JC, Mogensen J, Elliott PM, Smith GC, Elkington AG, Prasad SK, Pennell DJ, McKenna WJ.

Heart. 2005 Aug;91(8):1036-40.


Magnetic resonance imaging (MRI) of inflamed myocardium using iron oxide nanoparticles in patients with acute myocardial infarction - preliminary results.

Yilmaz A, Rösch S, Klingel K, Kandolf R, Helluy X, Hiller KH, Jakob PM, Sechtem U.

Int J Cardiol. 2013 Feb 20;163(2):175-82. doi: 10.1016/j.ijcard.2011.06.004.


Correlation of electrocardiographic changes and myocardial fibrosis in patients with hypertrophic cardiomyopathy detected by cardiac magnetic resonance imaging.

Song BG, Yang HS, Hwang HK, Kang GH, Park YH, Chun WJ, Oh JH.

Clin Cardiol. 2013 Jan;36(1):31-5. doi: 10.1002/clc.22062. Epub 2012 Oct 15. Retraction in: Clin Cardiol. 2013 Nov;36(11):711.


MR of the brain in mitochondrial myopathy.

Wray SH, Provenzale JM, Johns DR, Thulborn KR.

AJNR Am J Neuroradiol. 1995 May;16(5):1167-73.


Retinal manifestations in mitochondrial diseases associated with mitochondrial DNA mutation.

Isashiki Y, Nakagawa M, Ohba N, Kamimura K, Sakoda Y, Higuchi I, Izumo S, Osame M.

Acta Ophthalmol Scand. 1998 Feb;76(1):6-13.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk